{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:34:52Z","timestamp":1789396492255,"version":"build-2803163510"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Artificially sweetened beverages (ASBs) and sugar-sweetened beverages (SSBs) are widely consumed worldwide and have been linked to metabolic disorders, including obesity and type 2 diabetes, which are established risk factors associated with liver cancer. However, prospective evidence examining beverage consumption and liver cancer subtypes remains limited and inconsistent.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine associations between ASB and SSB consumption and risk of incident liver cancer overall and by subtype, including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n In this pooled analysis of 11 prospective cohort studies (10 US cohorts and 1 European cohort, comprising adults without a history of cancer at baseline), participants were enrolled across cohorts between 1980 and 2009 and followed up through end-of-study dates ranging from 2000 to 2019. The median (IQR) duration of follow-up was 11.4 (10.8-27.9) to 31.4 (27.6-31.5) years. This analysis was conducted between September 2024 and August 2025. Participants were followed up via linkage to state cancer registries or follow-up surveys for incident liver cancer.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Self-reported intake of ASB and SSB assessed at baseline using validated food frequency questionnaires and analyzed per 1-beverage\/day increment.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Incident liver cancer overall and by subtype (HCC and ICC) identified through cancer registries or medical record review. Cox proportional hazards regression models were used to estimate multivariable hazard ratios (HRs) and 95% CIs for liver cancer incidence, adjusting for potential confounders, including demographics and lifestyle factors, and weighted-mean meta-analysis of estimates.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 1\u202f518\u202f411 participants (mean [SD] age, 57.8 [10.1] years; 883\u202f832 female [58.2%]) were included in this analysis. During a median (IQR) of 17.8 (12.8\u201323.5) years of follow-up, 2811 incident liver cancer cases were identified, including 1699 HCC and 444 ICC cases. After multivariable adjustment, ASB intake per 1-beverage\/day increase was not associated with liver cancer risk, HCC (10 cohorts), or ICC (6 cohorts). SSB intake per 1-beverage\/day increase was not associated with overall liver cancer risk but was associated with increased risk of HCC (HR, 1.10; 95% CI, 1.03-1.18; 10 cohorts) and ICC (HR, 1.15; 95% CI, 1.00-1.32; 6 cohorts). There was no evidence of effect modification by diabetes status.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this study, increased SSB consumption was associated with increased risk of HCC and ICC. There was little evidence that ASB intake was associated with liver cancer risk overall or by subtype.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.17754","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:30:51Z","timestamp":1781105451000},"page":"e2617754","source":"Crossref","is-referenced-by-count":3,"title":["Artificially Sweetened and Sugar-Sweetened Beverage Intake and Risk of Liver Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Cody Z.","family":"Watling","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longgang","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Nursing, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Deubler","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo G.","family":"Gonzalez-Feliciano","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Graubard","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Petrick","sequence":"additional","affiliation":[{"name":"Slone Epidemiology Center at Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aika","family":"Wojt","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Butera","sequence":"additional","affiliation":[{"name":"Office of Research Services, Division of Library Services, National Institutes of Health Library, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Beane Freeman","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha J.","family":"Shrubsole","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci L.","family":"Sudenga","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schernhammer","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Epidemiology, Harvard T.H Chan School of Public Health, Harvard University, Boston, Massachusetts"},{"name":"Department of Epidemiology, Medical University of Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Heather","family":"Eliassen","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Epidemiology, Harvard T.H Chan School of Public Health, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei A.","family":"Mucci","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H Chan School of Public Health, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D.","family":"Sesso","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Sinha","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erikka","family":"Loftfield","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Y.","family":"Um","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie L.","family":"McCullough","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazda","family":"Jenab","sequence":"additional","affiliation":[{"name":"Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Nursing, Yale University, New Haven, Connecticut"},{"name":"Department of Epidemiology, Yale School of Public health, New Haven, Connecticut"},{"name":"Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"McGlynn","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"3","key":"zoi260501r1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"zoi260501r2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040.","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"12","key":"zoi260501r4","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/ijc.31280","article-title":"Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide.","volume":"142","author":"Maucort-Boulch","year":"2018","journal-title":"Int J Cancer"},{"issue":"8","key":"zoi260501r5","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/annonc\/mdu020","article-title":"Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies.","volume":"25","author":"Turati","year":"2014","journal-title":"Ann Oncol"},{"issue":"7","key":"zoi260501r6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41416-018-0007-z","article-title":"Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project.","volume":"118","author":"Petrick","year":"2018","journal-title":"Br J Cancer"},{"issue":"14","key":"zoi260501r7","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/j.ejca.2012.02.009","article-title":"Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis.","volume":"48","author":"Liu","year":"2012","journal-title":"Eur J Cancer"},{"issue":"20","key":"zoi260501r8","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1158\/0008-5472.CAN-16-0787","article-title":"Body mass index, waist circumference, diabetes, and risk of liver cancer for U.S. adults.","volume":"76","author":"Campbell","year":"2016","journal-title":"Cancer Res"},{"issue":"7","key":"zoi260501r9","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.bjc.6603932","article-title":"Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies.","volume":"97","author":"Larsson","year":"2007","journal-title":"Br J Cancer"},{"issue":"8","key":"zoi260501r10","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ajg.2013.160","article-title":"Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.","volume":"108","author":"Welzel","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"zoi260501r11","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1470-2045(23)00341-8","article-title":"Carcinogenicity of aspartame, methyleugenol, and isoeugenol.","volume":"24","author":"Riboli","year":"2023","journal-title":"Lancet Oncol"},{"issue":"10","key":"zoi260501r13","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1158\/1055-9965.EPI-22-0392","article-title":"Sugar- and artificially-sweetened beverages and cancer mortality in a large U.S. prospective cohort.","volume":"31","author":"McCullough","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"zoi260501r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2022.102201","article-title":"Sweetened beverage consumption and risk of liver cancer by diabetes status: a pooled analysis.","volume":"79","author":"Jones","year":"2022","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"zoi260501r15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00394-014-0818-5","article-title":"Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort.","volume":"55","author":"Stepien","year":"2016","journal-title":"Eur J Nutr"},{"issue":"1","key":"zoi260501r17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajcnut.2022.11.008","article-title":"Sugar-sweetened beverage consumption and weight gain in children and adults: a systematic review and meta-analysis of prospective cohort studies and randomized controlled trials.","volume":"117","author":"Nguyen","year":"2023","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"zoi260501r18","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.2337\/dc10-1079","article-title":"Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis.","volume":"33","author":"Malik","year":"2010","journal-title":"Diabetes Care"},{"key":"zoi260501r19","doi-asserted-by":"publisher","first-page":"h3576","DOI":"10.1136\/bmj.h3576","article-title":"Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction.","volume":"351","author":"Imamura","year":"2015","journal-title":"BMJ"},{"issue":"11","key":"zoi260501r20","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.cgh.2021.11.001","article-title":"Sugar-sweetened beverage, diet soda, and nonalcoholic fatty liver disease over 6 years: the Framingham Heart Study.","volume":"20","author":"Park","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"zoi260501r21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3945\/ajcn.111.022533","article-title":"Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study.","volume":"95","author":"Maersk","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"zoi260501r22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"zoi260501r23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jama.2023.12618","article-title":"Sugar-sweetened and artificially sweetened beverages and risk of liver cancer and chronic liver disease mortality.","volume":"330","author":"Zhao","year":"2023","journal-title":"JAMA"},{"issue":"12","key":"zoi260501r24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/aje\/154.12.1119","article-title":"Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study.","volume":"154","author":"Schatzkin","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"4","key":"zoi260501r25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1289\/ehp.96104362","article-title":"The agricultural health study.","volume":"104","author":"Alavanja","year":"1996","journal-title":"Environ Health Perspect"},{"issue":"2","key":"zoi260501r26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/cncr.10197","article-title":"The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.","volume":"94","author":"Calle","year":"2002","journal-title":"Cancer"},{"key":"zoi260501r27","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/ije\/26.suppl_1.S6","article-title":"The EPIC Project: rationale and study design: European prospective investigation into cancer and nutrition.","volume":"26","author":"Riboli","year":"1997","journal-title":"Int J Epidemiol"},{"issue":"15","key":"zoi260501r28","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1056\/NEJM199010113231504","article-title":"Coffee, caffeine, and cardiovascular disease in men.","volume":"323","author":"Grobbee","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi260501r29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/jwh.1997.6.49","article-title":"The Nurses\u2019 Health Study: 20-year contribution to the understanding of health among women.","volume":"6","author":"Colditz","year":"1997","journal-title":"J Womens Health"},{"issue":"2","key":"zoi260501r30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1047-2797(99)00042-3","article-title":"Design of Physicians\u2019 Health Study II\u2014a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.","volume":"10","author":"Christen","year":"2000","journal-title":"Ann Epidemiol"},{"issue":"6","key":"zoi260501r31","doi-asserted-by":"publisher","first-page":"251S","DOI":"10.1016\/S0197-2456(00)00097-0","article-title":"The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial of the National Cancer Institute: history, organization, and status.","volume":"21","author":"Gohagan","year":"2000","journal-title":"Control Clin Trials"},{"issue":"1","key":"zoi260501r32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1353\/hpu.0.0245","article-title":"The Southern Community Cohort Study: investigating health disparities.","volume":"21","author":"Signorello","year":"2010","journal-title":"J Health Care Poor Underserved"},{"issue":"9","key":"zoi260501r33","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/S1047-2797(03)00043-7","article-title":"Implementation of the Women\u2019s Health Initiative study design.","volume":"13","author":"Anderson","year":"2003","journal-title":"Ann Epidemiol"},{"issue":"1","key":"zoi260501r34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/152460900318911","article-title":"Baseline characteristics of participants in the Women\u2019s Health Study.","volume":"9","author":"Rexrode","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"issue":"1","key":"zoi260501r35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/oxfordjournals.aje.a114086","article-title":"Reproducibility and validity of a semiquantitative food frequency questionnaire.","volume":"122","author":"Willett","year":"1985","journal-title":"Am J Epidemiol"},{"issue":"12","key":"zoi260501r36","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.14309\/ajg.0000000000000450","article-title":"Type 2 diabetes prevention diet and hepatocellular carcinoma risk in US men and women.","volume":"114","author":"Luo","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"zoi260501r37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10654-020-00655-y","article-title":"Sugar and artificially sweetened beverages and risk of obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies.","volume":"35","author":"Qin","year":"2020","journal-title":"Eur J Epidemiol"},{"issue":"142","key":"zoi260501r38","first-page":"38285","article-title":"Aspartame: commissioner\u2019s final decision.","volume":"46","year":"1981","journal-title":"Fed Regist"},{"issue":"10","key":"zoi260501r39","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/annonc\/mdh256","article-title":"Artificial sweeteners\u2014do they bear a carcinogenic risk?","volume":"15","author":"Weihrauch","year":"2004","journal-title":"Ann Oncol"},{"issue":"2 Pt 2","key":"zoi260501r40","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1006\/rtph.2002.1542","article-title":"Aspartame: review of safety.","volume":"35","author":"Butchko","year":"2002","journal-title":"Regul Toxicol Pharmacol"},{"issue":"9","key":"zoi260501r41","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1289\/ehp.7542","article-title":"Meeting report: summary of IARC monographs on formaldehyde, 2-butoxyethanol, and 1-tert-butoxy-2-propanol.","volume":"113","author":"Cogliano","year":"2005","journal-title":"Environ Health Perspect"},{"issue":"8","key":"zoi260501r42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/10408440701516184","article-title":"Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.","volume":"37","author":"Magnuson","year":"2007","journal-title":"Crit Rev Toxicol"},{"issue":"12","key":"zoi260501r44","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/oby.21310","article-title":"Sugar- and artificially sweetened beverages and intrahepatic fat: a randomized controlled trial.","volume":"23","author":"Campos","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"zoi260501r45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118089","article-title":"Aspartame increases the risk of liver cancer through CASP1 protein: a comprehensive network analysis insights.","volume":"294","author":"Li","year":"2025","journal-title":"Ecotoxicol Environ Saf"},{"issue":"15","key":"zoi260501r46","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1203388","article-title":"A randomized trial of sugar-sweetened beverages and adolescent body weight.","volume":"367","author":"Ebbeling","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi260501r47","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41591-024-03345-4","article-title":"Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries.","volume":"31","author":"Lara-Castor","year":"2025","journal-title":"Nat Med"},{"issue":"2","key":"zoi260501r48","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/annonc\/mds434","article-title":"Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans.","volume":"24","author":"Fedirko","year":"2013","journal-title":"Ann Oncol"},{"issue":"11","key":"zoi260501r49","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1158\/1940-6207.CAPR-16-0141","article-title":"Higher glucose and insulin levels are associated with risk of liver cancer and chronic liver disease mortality among men without a history of diabetes.","volume":"9","author":"Loftfield","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"zoi260501r50","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.27016","article-title":"Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.","volume":"60","author":"Aleksandrova","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"zoi260501r51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jama.2018.20579","article-title":"Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial.","volume":"321","author":"Schwimmer","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"zoi260501r52","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease.","volume":"68","author":"Jensen","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"zoi260501r53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.","volume":"7","author":"Lim","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"zoi260501r12","volume-title":"Aspartame, Methyleugenol, and Isoeugenol: IARC Monographs on the Identification of Carcinogenic Hazards to Humans: Volume 134","author":"International Agency for Research on Cancer","year":"2024"},{"key":"zoi260501r3","unstructured":"American Cancer Society. Key statistics about liver cancer. August 6, 2023. Accessed April 28, 2026. https:\/\/www.cancer.org\/cancer\/types\/liver-cancer\/about\/what-is-key-statistics.html"},{"key":"zoi260501r16","doi-asserted-by":"crossref","unstructured":"Naddaf? M. Aspartame is a possible carcinogen: the science behind the decision. Nature. Accessed April 28, 2026. https:\/\/www.nature.com\/articles\/d41586-023-02306-0 doi:10.1038\/d41586-023-02306-0?","DOI":"10.1038\/d41586-023-02306-0"},{"key":"zoi260501r43","unstructured":"US Food and Drug Administration. Aspartame and other sweeteners in food. Accessed July 7, 2025. https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2850133\/watling_2026_oi_260501_1780432331.98269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:30:56Z","timestamp":1781105456000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2850133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.17754","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}